horizon Logo (EUIPO, 06/12/2013)
EUIPOProtect this trademark from copycats!
With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.
The Union trademark horizon was filed as Figurative mark on 06/12/2013 at the European Union Intellectual Property Office.
It was registered as a trademark on 11/11/2015.
The current status of the mark is "Trademark registered".
Logodesign (Wiener Klassifikation)
#Letters presenting a special form of writing
| Trademark form | Figurative mark |
| File reference | 011894292 |
| Application date | June 12, 2013 |
| Publication date | August 1, 2013 |
| Entry date | November 11, 2015 |
| Expiration date | June 12, 2033 |
Trademark owner
8100 Cambridge Research Park Waterbeach
CB25 9TL Cambridge
GB
CB25 9TL Cambridge
GB
Trademark representatives
55, rue des Bruyères
1274 Howald
LU
Objection / Complaint
10/30/2013: Likelihood of confusion
Applicant
ORYZON GENOMICS, S.A.
goods and services
1
Human cells and isogenic cell lines for scientific, laboratory or medical research; genomic reference control samples for medical laboratory use; Molecular biology research tools, in the nature of biological and biochemical reagents, specifically, genomic DNA; DNA repair enzymes; biological and chemical reagents, including, genomic DNA, cell cultures and mutant and normal isogenic human cell line pairs, for research use
5
Protein cell lysates, genomic DNA preparations and FFPE engineered tumor mimics for diagnostic use
42
Custom cell-line engineering services; gene-editing services; DNA modeling services; gene engineering services; bio-technology, pharmaceutical and scientific testing, research, development, advice, consultancy and information services; biological research; biology and chemistry services; pharmaceutical research services; drug discovery services; research and development services for lead identification and validation; research and development services for target identification and validation; identification of patient-relevant drug targets; optimisation of drug candidates for clinical development; diagnostic services; medicinal and synthetic chemistry services; research and development services in the creation of libraries or collections of biologicals including cells and cell lines, chemicals and compounds; creating libraries or collections of normal and mutated genes; research and development services relating to targeting therapies to individuals; establishing patient genotypes; research and development services relating to combining therapies for individuals; research and development relating to reagents; disease modelling; design of clinical trials; research and development in re-positioning existing drugs from other therapeutic indications
Trademark history
| Date | Document number | Area | Entry |
|---|---|---|---|
| May 15, 2023 | Extension, Trade mark renewed | ||
| May 5, 2023 | Transfer / Change of address, Published | ||
| January 19, 2021 | Change Representative, Published | ||
| January 7, 2021 | RAW: Representative - Deletion of the representative, Published | ||
| October 20, 2014 | Change Representative, Published | ||
| September 11, 2014 | Change Representative, Registered |
ID: 11011894292